TCTC Holdings’s Quest Diagnostics DGX Stock Holding History

TCTC Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-121	Closed	-$21K	–	299
2025 Q4	$21K	Hold	121	–	–	﹤0.01%	439
2025 Q3	$23.1K	Hold	121	–	–	﹤0.01%	425
2025 Q2	$21.7K	Hold	121	–	–	﹤0.01%	454
2025 Q1	$20.5K	Buy	+121	New	+$19.9K	﹤0.01%	463
2023 Q4	–	Sell	-148	Closed	-$18K	–	509
2023 Q3	$18K	Hold	148	–	–	﹤0.01%	333
2023 Q2	$20.8K	Hold	148	–	–	﹤0.01%	322
2023 Q1	$20.9K	Hold	148	–	–	﹤0.01%	342
2022 Q4	$23.2K	Hold	148	–	–	﹤0.01%	323
2022 Q3	$18K	Hold	148	–	–	﹤0.01%	320
2022 Q2	$20K	Hold	148	–	–	﹤0.01%	320
2022 Q1	$20K	Hold	148	–	–	﹤0.01%	333
2021 Q4	$26K	Hold	148	–	–	﹤0.01%	343
2021 Q3	$22K	Hold	148	–	–	﹤0.01%	362
2021 Q2	$20K	Hold	148	–	–	﹤0.01%	334
2021 Q1	$19K	Hold	148	–	–	﹤0.01%	329
2020 Q4	$18K	Buy	+148	New	+$18K	﹤0.01%	317

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

TCTC Holdings's DGX Position: Q1 2026 in Review

TCTC Holdings sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 121 shares — an estimated $21K sold.

TCTC Holdings first reported a position in DGX in Q4 2020 and held it in 16 quarters. The position peaked at $26K in Q4 2021. 1,067 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

TCTC Holdings reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
TCTC Holdings sold 121 Quest Diagnostics shares in Q1 2026, an estimated $21K.
TCTC Holdings first reported a position in Quest Diagnostics in Q4 2020 and held it in 16 quarters.
TCTC Holdings's Quest Diagnostics position peaked at $26K in Q4 2021.
1,067 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.